Temasek Holdings Portfolio holdings
AUM
$37.3B
Turnover
40.09%
1-Year Est. Return
12.6%
This Fund
S&P 500
This Quarter
Est. Return
-0.17%
1 Year Est. Return
+12.6%
3 Year Est. Return
+93.72%
5 Year Est. Return
+64.47%
10 Year Est. Return
+501.94%
AUM
$16.3B
AUM Growth
-$906M
(-5.3%)
Cap. Flow
-$922M
Cap. Flow
% of AUM
-5.67%
Top 10 Holdings %
Top 10 Hldgs %
71.33%
Holding
67
New
6
Increased
8
Reduced
6
Closed
4
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumen Technologies, Inc. Common Stock
LUMN
|
+$1.58B |
| 2 |
DuPont de Nemours
DD
|
+$400M |
| 3 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$178M |
| 4 |
Boeing
BA
|
+$142M |
| 5 |
BeOne Medicines Ltd
ONC
|
+$82.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVLT
Level 3 Communications Inc
LVLT
|
+$3.47B |
| 2 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$46.4M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$9.88M |
| 4 |
JPMorgan Chase
JPM
|
+$8.92M |
| 5 |
Bank of America
BAC
|
+$7.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 43.88% |
| 2 | Healthcare | 15.43% |
| 3 | Communication Services | 14.5% |
| 4 | Financials | 8.64% |
| 5 | Materials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Alibaba
BABA
$277B
| $6.12B | 37.62% |
35,495,289
| – | – |
2014 Q3
13 quarters
|
|
|
2
Lumen Technologies, Inc. Common Stock
LUMN
$4.69B
| $1.55B | 9.52% |
+92,904,239
| New | +$1.58B |
2017 Q4
0 quarters
|
|
3
Gilead Sciences
GILD
$190B
| $797M | 4.9% |
11,125,816
| – | – |
2013 Q4
16 quarters
|
|
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $783M | 4.81% |
17,336,588
| – | – |
2014 Q3
13 quarters
|
|
|
UNVR
5
DELISTED
Univar Solutions Inc.
UNVR
| $439M | 2.7% |
14,171,599
| – | – |
2015 Q2
10 quarters
|
|
6
Visa
V
$735B
| $417M | 2.57% |
3,660,475
+367,700
| +11% | +$40.6M |
2016 Q4
4 quarters
|
|
|
7
DuPont de Nemours
DD
$17.4B
| $400M | 2.46% |
+2,219,267
| New | +$400M |
2017 Q4
0 quarters
|
|
8
PayPal
PYPL
$48B
| $397M | 2.44% |
5,387,963
| – | – |
2015 Q3
9 quarters
|
|
9
Virtu Financial
VIRT
$4.9B
| $372M | 2.29% |
20,330,503
| – | – |
2015 Q2
10 quarters
|
|
10
Trip.com Group
TCOM
$24.5B
| $329M | 2.02% |
7,464,928
+208,000
| +3% | +$9.94M |
2016 Q3
5 quarters
|
|
11
BioMarin Pharmaceuticals
BMRN
$10.7B
| $310M | 1.9% |
3,472,712
| – | – |
2014 Q1
15 quarters
|
|
12
JD.com
JD
$36B
| $303M | 1.86% |
7,306,572
| – | – |
2015 Q4
8 quarters
|
|
13
Thermo Fisher Scientific
TMO
$249B
| $285M | 1.75% |
1,503,087
| – | – |
2014 Q1
15 quarters
|
|
|
TRQ
14
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $251M | 1.54% |
7,321,388
| – | – |
2013 Q2
18 quarters
|
|
|
PTLA
15
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $238M | 1.46% |
4,883,568
| – | – |
2013 Q2
18 quarters
|
|
16
PPG Industries
PPG
$23.3B
| $202M | 1.24% |
1,727,645
| – | – |
2016 Q4
4 quarters
|
|
17
DELISTED
Newfield Exploration
NFX
| $199M | 1.23% |
6,326,046
| – | – |
2017 Q2
2 quarters
|
|
|
RDS.B
18
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $196M | 1.2% |
2,868,867
| – | – |
2016 Q3
5 quarters
|
|
19
ZTO Express
ZTO
$15.2B
| $193M | 1.19% |
12,176,750
| – | – |
2016 Q4
4 quarters
|
|
|
AQUA
20
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $192M | 1.18% |
+8,087,290
| New | +$178M |
2017 Q4
0 quarters
|
|
21
Antero Resources
AR
$11.3B
| $185M | 1.14% |
9,755,618
| – | – |
2016 Q4
4 quarters
|
|
|
ALXN
22
DELISTED
Alexion Pharmaceuticals
ALXN
| $180M | 1.11% |
1,505,325
| – | – |
2015 Q2
10 quarters
|
|
|
23
Boeing
BA
$146B
| $155M | 0.95% |
+525,636
| New | +$142M |
2017 Q4
0 quarters
|
|
24
Amazon
AMZN
$2.74T
| $154M | 0.95% |
2,634,700
| – | – |
2016 Q4
4 quarters
|
|
|
GRA
25
DELISTED
W.R. Grace & Co.
GRA
| $153M | 0.94% |
2,187,501
| – | – |
2017 Q2
2 quarters
|
|
Similar funds
ECSS
PIF
TWC
Temasek Holdings's Q4 2017 Portfolio in Review
As of Q4 2017, Temasek Holdings held 67 positions worth $16.3B, down 5.3% from $17.2B the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Temasek Holdings withdrew a net $922M in Q4 2017, closing 4 positions and reducing 6 holdings. Its most notable exit was Level 3 Communications Inc, an estimated $3.47B position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 44% of assets, up from 42% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Temasek Holdings opened a new position in Lumen Technologies, Inc. Common Stock worth $1.55B.
- Temasek Holdings's largest Q4 2017 buy was Lumen Technologies, Inc. Common Stock: 92,904,239 shares worth $1.55B.
- Temasek Holdings added most to BeOne Medicines Ltd in Q4 2017, an estimated $82.4M increase.
- Temasek Holdings's biggest Q4 2017 reduction was State Street SPDR S&P Regional Banking ETF, cutting an estimated $9.88M.
- Temasek Holdings fully exited Level 3 Communications Inc in Q4 2017, selling an estimated $3.47B.
- Temasek Holdings's ten largest holdings make up 71% of its $16.3B portfolio in Q4 2017.
- Temasek Holdings opened 6 new positions and closed 4 in Q4 2017.
- Temasek Holdings's portfolio value fell 5.3% quarter-over-quarter to $16.3B.
Based on Temasek Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.